Cefotaxime Injection, Powder, For Solution
Product Images NDC 0143-9930

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Cefotaxime (NDC 0143-9930). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Structural Formula (Cefotaxime For Injection 1)

Structural Formula (Cefotaxime For Injection 1)
Chemical structure of the active ingredient Cefotaxime, showing its molecular configuration with key functional groups and atoms including sulfur, nitrogen, oxygen, and sodium.*
FDA Label Image

Ndc 0143-9930-01 Cefotaxime For Injection, Usp 500 mg*/vial For Iv Or Im Use Rx Only *each Vial Contains Sterile Cefotaxime Sodium Equivalent To 500 mg Cefotaxime. The Sodium Content Is Approximately 50.5 mg (2.2 Meq) Of Sodium Per Gram Cefotaxime. Dosage, Administration And Reconstitution: See Package Insert. Shake To Dissolve. Retain In Carton Until Time Of Use. Storage: Cefotaxime For Injection In The Dry State Should Be Stored At 20º To 25ºc (68º To 77ºf) [see Usp Controlled Room Temperature]. Protect From Light. (Cefotaxime For Injection 2)

Ndc 0143-9930-01 Cefotaxime For Injection, Usp 500 mg*/vial For Iv Or Im Use Rx Only *each Vial Contains Sterile Cefotaxime Sodium Equivalent To 500 mg Cefotaxime. The Sodium Content Is Approximately 50.5 mg (2.2 Meq) Of Sodium Per Gram Cefotaxime. Dosage, Administration And Reconstitution: See Package Insert. Shake To Dissolve. Retain In Carton Until Time Of Use. Storage: Cefotaxime For Injection In The Dry State Should Be Stored At 20º To 25ºc (68º To 77ºf) [see Usp Controlled Room Temperature]. Protect From Light. (Cefotaxime For Injection 2)
Label for Cefotaxime 500 mg per vial injection, powder for solution. Indicated for intravenous or intramuscular use. Manufactured by Hikma Farmaceutica (Portugal), distributed by Hikma Pharmaceuticals USA Inc., Berkeley Heights, NJ. The label includes storage and handling instructions, lot and expiration date fields, and a barcode.*
FDA Label Image

Ndc 0143-9931-01 Cefotaxime For Injection, Usp 1 G*/vial For Iv Or Im Use Rx Only *each Vial Contains Sterile Cefotaxime Sodium Equivalent To 1 G Cefotaxime. The Sodium Content Is Approximately 50.5 mg (2.2 Meq) Of Sodium Per Gram Cefotaxime. Dosage, Administration And Reconstitution: See Package Insert. Shake To Dissolve. Retain In Carton Until Time Of Use. Storage: Cefotaxime For Injection In The Dry State Should Be Stored At 20º To 25ºc (68º To 77ºf) [see Usp Controlled Room Temperature]. Protect From Light. (Cefotaxime For Injection 3)

Ndc 0143-9931-01 Cefotaxime For Injection, Usp 1 G*/vial For Iv Or Im Use Rx Only *each Vial Contains Sterile Cefotaxime Sodium Equivalent To 1 G Cefotaxime. The Sodium Content Is Approximately 50.5 mg (2.2 Meq) Of Sodium Per Gram Cefotaxime. Dosage, Administration And Reconstitution: See Package Insert. Shake To Dissolve. Retain In Carton Until Time Of Use. Storage: Cefotaxime For Injection In The Dry State Should Be Stored At 20º To 25ºc (68º To 77ºf) [see Usp Controlled Room Temperature]. Protect From Light. (Cefotaxime For Injection 3)
Label for Cefotaxime for Injection, USP 500 mg per vial, a powder injection for intravenous or intramuscular use. The label indicates each vial contains sterile cefotaxime sodium equivalent to 500 mg cefotaxime. The package contains 10 vials of 500 mg each. Manufactured by Hikma Pharmaceuticals USA Inc.*
FDA Label Image

Ndc 0143-9933-01 Cefotaxime For Injection, Usp 2 G*/vial For Iv Or Im Use Rx Only *each Vial Contains Sterile Cefotaxime Sodium Equivalent To 2 G Cefotaxime. The Sodium Content Is Approximately 50.5 mg (2.2 Meq) Of Sodium Per Gram Cefotaxime. Dosage, Administration And Reconstitution: See Package Insert. Shake To Dissolve. Retain In Carton Until Time Of Use. Storage: Cefotaxime For Injection In The Dry State Should Be Stored At 20º To 25ºc (68º To 77ºf) [see Usp Controlled Room Temperature]. Protect From Light. (Cefotaxime For Injection 4)

Ndc 0143-9933-01 Cefotaxime For Injection, Usp 2 G*/vial For Iv Or Im Use Rx Only *each Vial Contains Sterile Cefotaxime Sodium Equivalent To 2 G Cefotaxime. The Sodium Content Is Approximately 50.5 mg (2.2 Meq) Of Sodium Per Gram Cefotaxime. Dosage, Administration And Reconstitution: See Package Insert. Shake To Dissolve. Retain In Carton Until Time Of Use. Storage: Cefotaxime For Injection In The Dry State Should Be Stored At 20º To 25ºc (68º To 77ºf) [see Usp Controlled Room Temperature]. Protect From Light. (Cefotaxime For Injection 4)
Cefotaxime 1 g per vial, injection powder for solution, USP. Label indicates use for intravenous or intramuscular administration. The label provides storage instructions, dosage and administration notes, and manufacturer details: Hikma Farmacêutica (Portugal) and distributor Hikma Pharmaceuticals USA Inc., Berkeley Heights, NJ. Includes vial contents description and lot/expiration information area.*
FDA Label Image

Cefotaxime For Injection 5

Cefotaxime For Injection 5
Label for Cefotaxime for Injection, USP 1 g per vial powder for solution injection. The vial is intended for intravenous or intramuscular use. The product is distributed by Hikma Pharmaceuticals USA Inc., with manufacturing by Hikma Farmacêutica in Portugal. The label includes storage instructions, dosage reconstitution directions, and a barcode.*
FDA Label Image

Cefotaxime For Injection 6

Cefotaxime For Injection 6
Cefotaxime 2 g vial injection powder label for solution by Hikma Pharmaceuticals USA Inc. The label states it is for intravenous or intramuscular use, with storage instructions to keep between 20° to 25°C and to protect from light. It also includes manufacturer and distributor information and directions to shake to dissolve and refer to package insert for dosage and reconstitution.*
FDA Label Image

Cefotaxime For Injection 7

Cefotaxime For Injection 7
A label featuring a QR code and alphanumeric text displaying GTIN, serial number, expiration date placeholder, and lot number placeholder. The label is associated with Cefotaxime injection, powder for solution by Hikma Pharmaceuticals USA Inc., but the image shows only identification and tracking information, not product packaging details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.